Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Controlled Pilot Trial of Pregnenolone in Autism
NCT02627508Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jan 2016
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Autism Spectrum Disorder (ASD) comparing Pregnenolone (up to 500 mg per day) with Placebo (2 arms). Primary endpoint: Aberrant Behavior Checklist Irritability at 14 weeks. Started Jan 2016; status: completed.
02
Drugs
pregnenolone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02627508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02627508.